Infectious Diseases News and Research RSS Feed - Infectious Diseases News and Research

Single dose of oral cholera vaccine could save more lives in crisis situations

Single dose of oral cholera vaccine could save more lives in crisis situations

An oral cholera vaccine that is in short supply could treat more people and save more lives in crisis situations, if one dose were dispensed instead of the recommended two, new Johns Hopkins Bloomberg School of Public Health research suggests. [More]
Theresa Alenghat receives 2015 AGA-CCFA-Janssen Research Award in IBD Epigenetics Research

Theresa Alenghat receives 2015 AGA-CCFA-Janssen Research Award in IBD Epigenetics Research

The American Gastroenterological Association, in partnership with the Crohn's & Colitis Foundation of America and Janssen Biotech, Inc., announced today that Theresa Alenghat, VMD, PhD, from Cincinnati Children's Hospital Medical Center, OH, was awarded with the 2015 AGA-CCFA-Janssen Research Award in Inflammatory Bowel Disease (IBD) Epigenetics Research. [More]
iCo Therapeutics incurs total comprehensive loss of $738,607 for second quarter 2015

iCo Therapeutics incurs total comprehensive loss of $738,607 for second quarter 2015

iCo Therapeutics, today reported financial results for the quarter ended June 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). [More]
Antiviral-based therapies have potential to protect humans from deadly Ebola virus

Antiviral-based therapies have potential to protect humans from deadly Ebola virus

For the first time, UK physicians have demonstrated that antiviral-based therapies have the potential to protect humans from the deadly Ebola virus. The report, published in The Lancet Infectious Diseases journal, describes a case-series of eight British health-care workers who were evacuated to the Royal Free Hospital in London, UK after possible accidental exposure to Ebola virus in Sierra Leone between January and March 2015. [More]

New £5.4 million grant may accelerate discovery, application of advanced materials in healthcare

A new £5.4 million grant for research aimed at accelerating the discovery and application of new advanced materials in healthcare was announced today by the Engineering and Physical Sciences Research Council. [More]
New studies evaluate viral suppression rate of HIV-infected pregnant women at delivery

New studies evaluate viral suppression rate of HIV-infected pregnant women at delivery

Pregnancy could be a turning point for HIV-infected women, when they have the opportunity to manage their infection, prevent transmission to their new baby and enter a long-term pattern of maintenance of HIV care after giving birth--but most HIV-infected women aren't getting that chance. [More]
Researchers discover new hepatitis A-like virus in seals

Researchers discover new hepatitis A-like virus in seals

Scientists in the Center for Infection and Immunity at Columbia University's Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A. [More]
BD Life Sciences completes acquisition of Cellular Research

BD Life Sciences completes acquisition of Cellular Research

BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company), today announced it has completed the acquisition of Cellular Research, Inc. [More]
Study: Influenza vaccines offer sustained protection up to 6 months during flu season

Study: Influenza vaccines offer sustained protection up to 6 months during flu season

Individuals who received the flu vaccine were protected for up to 6 months post-vaccination, the duration of most flu seasons, according to a study presented at the 2015 International Conference on Emerging Infectious Diseases. [More]
Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

In response to the growing opioid crisis, several states, including Massachusetts and Rhode Island, have granted pharmacists the authority to provide naloxone rescue kits without a prescription to at-risk patients. This model of pharmacy-based naloxone (PBN) education and distribution is one of the public health strategies currently being evaluated at hundreds of pharmacies in both states to determine the impact on opioid overdose death rates. [More]
New ASU-POSTECH collaboration aims to discover biological molecules for health care, renewable energy research

New ASU-POSTECH collaboration aims to discover biological molecules for health care, renewable energy research

The Biodesign Institute at Arizona State University and Pohang University of Science and Technology (POSTECH), Pohang, South Korea, have announced a partnership that will catalyze discoveries with a major impact on health care and clean energy applications. [More]
Novel synthetic DNA vaccine induces protective immunity against MERS virus in animal study

Novel synthetic DNA vaccine induces protective immunity against MERS virus in animal study

A novel synthetic DNA vaccine can, for the first time, induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species, reported researchers from the Perelman School of Medicine at the University of Pennsylvania. [More]
Analysis of toilet waste from international aircraft may lead to global surveillance of infectious diseases

Analysis of toilet waste from international aircraft may lead to global surveillance of infectious diseases

Current international disease surveillance systems are mainly based on reports made by doctors after treatment of infected patients. As a consequence, disease-causing microorganisms and resistance bacteria have time to spread and make large population groups sick before they are detected. [More]
Discovery provides new insights into how asthma may be caused

Discovery provides new insights into how asthma may be caused

Researchers from the University of Leicester and University Hospitals of Leicester NHS Trust, working with the National Institute of Allergy and Infectious Diseases and Genentech, have discovered new insights into how asthma may be caused, by identifying three distinct groups of asthma patients characterised by the activity of different genes in an individual's airways. [More]
Penn State College of Medicine students to work with medical educators to design new curriculum

Penn State College of Medicine students to work with medical educators to design new curriculum

The medical school model that has existed for decades involves two years of study in the basic sciences followed by two years of clinical study. An initiative under way at Penn State College of Medicine will involve students in developing a new curriculum that integrates the two areas of study, with a goal of preparing physicians for the new realities of health care. [More]
Experimental MERS-CoV vaccine shows promise in monkeys and camels

Experimental MERS-CoV vaccine shows promise in monkeys and camels

National Institutes of Health scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease. The vaccine also generated potentially protective MERS-CoV antibodies in blood drawn from vaccinated camels. [More]
Having depressed friends doesn't affect your mental health, study finds

Having depressed friends doesn't affect your mental health, study finds

Having friends who suffer from depression doesn't affect the mental health of others, according to research led by the University of Warwick. [More]
NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax. [More]
Contact precaution use needs to be individualized to fit hospital's specific needs and resources

Contact precaution use needs to be individualized to fit hospital's specific needs and resources

Contact precautions are recommended by the Centers for Disease Control and Prevention for all patients known to be infected with or carrying multidrug-resistant organisms (MDROs) such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Yet, the use of contact precautions--which require a patient to be isolated in a single hospital room and health care providers to wear a gown and gloves when caring for patients--is widely debated in the medical community. [More]
Astellas Farma Brasil named one of Top 20 places to work in Brazil

Astellas Farma Brasil named one of Top 20 places to work in Brazil

Astellas Farma Brasil is one of the Top 20 small- to medium-sized companies to work for in the country across all industries, according to the Great Place to Work Institute's latest rankings. The results are based on a survey of thousands of employees across multiple industries in Brazil. [More]
Advertisement
Advertisement